Patent. CN117230202A 【IF: 0】Patent. CN117230202A 2023 Dec 15 Cell Counting Kit-8 purchased from AbMole
Patent. CN112137996B 【IF: 0】Patent. CN112137996B 2023 Aug 25 Dizocilpine purchased from AbMole
Patent. CN114606192B 【IF: 0】Patent. CN114606192B 2023 Aug 08 Recombinant Human TGF-β1 (CHO) purchased from AbMole
Patent. CN116769836A 【IF: 0】Patent. CN116769836A 2023 Sep 19 Y-27632 dihydrochloride purchased from AbMole
LncRNA GHET1 from bone mesenchymal stem cell–derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3 【IF: 】 2023 Jun Calcein-AM purchased from AbMole
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers 【IF: 69.504】Nature. 2022 Aug;608(7923):609-617 Y-27632 dihydrochloride purchased from AbMole
Deciphering the immunopeptidome in vivo reveals new tumour antigens 【IF: 69.504】Nature. 2022 Jul;607(7917):149-155 CHIR-99021 purchased from AbMole
Uncovering the mode of action of engineered T cells in patient cancer organoids 【IF: 68.164】Nat Biotechnol. 2022 Jul 25 Y-27632 dihydrochloride purchased from AbMole
Efficient targeted insertion of large DNA fragments without DNA donors 【IF: 47.99】Nat Methods. 2022 Mar;19(3):331-340 Nocodazole purchased from AbMole
Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression 【IF: 41.444】Mol Cancer. 2022 Mar 18;21(1):77 Rapamycin purchased from AbMole
Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3–eIF3h interaction 【IF: 41.444】Mol Cancer. 2022 Feb 14;21(1):49 Actinomycin D purchased from AbMole
Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants 【IF: 39.3】Signal Transduct Target Ther. 2022 May 17;7(1):159 FTY720 hydrochloride purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
